This dependency is exploited therapeutically, as PHGDH inhibition synergizes with NAMPT inhibition in Ewing sarcoma and with tyrosine kinase inhibitors in HCC to overcome chemoresistance [31, 68]. Here, PHGDH is linked to hepatocellular carcinoma.